Tag: the war on (some) drugs

Committee In Tennessee Signs Off On Proposal To Tighten Restrictions On Hemp Industry

Despite warnings that the hemp industry would be decimated, the House Judiciary Committee passed a measure Wednesday that would put stricter regulations in place.

Sponsored by House Majority Leader William Lamberth (R) of Portland, House Bill 1376 would place the industry under the Alcoholic Beverage Commission instead of the Department of Agriculture and remove products from convenience and grocery stores. Only vape and liquor stores would be allowed to sell some hemp products.

The House bill is set to be heard next in the Commerce Committee, where agreements with the industry could be reached.

“It does ban [derivatives] THCA and THCP. The reason for that is we have not legalized marijuana in this state,” Lamberth said.

Hemp is distinguished from marijuana in that it contains a compound called delta-9 THC. Cannabis with a concentration of less than 0.3 percent delta-9 THC is defined as legal hemp in Tennessee—and federally. Cannabis with concentrations greater than 0.3 percent is classified as marijuana and is illegal to grow, sell or possess in Tennessee.

Hemp flowers also contain THCA, a nonintoxicating acid that would be banned in Tennessee under this bill. When heated or smoked, the THCA in the plant converts into delta-9 THC—an illegal substance in Tennessee in greater than trace amounts.

Clint Palmer, a representative of the hemp industry, told lawmakers the bill is similar to one passed in 2023 that led to a lawsuit against the Department of Agriculture that remains in litigation.

Keep reading

Governor Youngkin’s expected cannabis veto: A $3.5 billion gift to Mexican cartels and Chinese gangs

As Governor Glenn Youngkin once again faces a bipartisan bill that would establish a regulated cannabis distribution platform in Virginia, it is widely anticipated that he will act against the public’s interest just as he did in March 2024. In the twelve months since his last veto, the only certainty is that Mexican cartels and Chinese gangs have benefited from $3.5 billion in untaxed, unregulated cannabis sales while the proliferation of hemp-based THC products has skyrocketed. We anticipate that Youngkin will once again roll out his prohibitionist arguments but will fail to point to any tangible decrease in illegal cannabis sales the over the last 12-month— further proving that gifting Mexican cartels and Chinese drug dealers $3.5 billion and allowing the proliferation of illegal stores from Arlington to the Tennessee state line has only benefited organized crime at the expense of Virginians.

Youngkin’s argument hinges on a fundamental contradiction. He acknowledges that Virginia’s current system is “pervasive and dangerous,” yet refuses to implement the one policy proven to reduce illegal markets — regulation. Instead, he clings to outdated scare tactics, misrepresenting data from other states while ignoring the realities of his own.

Prohibitionists once used the same flawed logic to keep whiskey illegal, relying on bootleggers to supply demand while enriching organized crime. The parallels to cannabis today are undeniable. By refusing to regulate cannabis, Youngkin is ensuring that the only suppliers are Mexican cartels and Chinese gangs, just as Prohibition once empowered the Mafia. This policy failure is not just historical irony — it is a $3.5 billion mistake.

Keep reading

Idaho Lawmakers Approve Measure To Block Voters From Being Able To Legalize Marijuana

The Idaho House passed a resolution on Wednesday seeking voter approval to amend the state constitution and give the Legislature exclusive authority to regulate marijuana.

House Joint Resolution 4 aims to eliminate voters’ ability to legalize marijuana through a ballot initiative. As a resolution, the legislation does not hold the force of law. Instead, it would place a question on Idahoans’ ballot about whether to amend Idaho’s Constitution to allow only the Legislature to have a say in legalizing “psychoactive substances.” A majority of voters would need to vote yes in order for the constitution to be amended.

Currently, a “Decriminalize Cannabis Now” ballot initiative is in the signature gathering process, according to VoteIdaho.gov. If it qualifies, and if the Senate approves House Joint Resolution 4, then both questions would appear on the 2026 ballot, sponsor Rep. Bruce Skaug, R-Nampa said.

Skaug said the resolution comes from a place of concern for the “virtue and sobriety” of Idahoans.

“It’s time for Idahoans to proactively decide the state’s fate relative to marijuana, psychoactive substances and narcotics,” Skaug said. “I’m asking that we let our state go on the offense.”

Keep reading

Marijuana Consumers Are Under Attack In Multiple States, And It’s Time To Fight Back

Seventy percent of Americans, including majorities of Democratic and Republican voters, say that marijuana should be legal for adults. Yet this legislative session, lawmakers from both parties are placing cannabis consumers in their crosshairs.

In Republican-led states like Montana, Nebraska, Ohio and South Dakota, lawmakers are seeking to either repeal or significantly roll back voter-approved legalization laws. In Democrat-led states like California, Maryland, Michigan and New Jersey, lawmakers are seeking to undermine existing legalization markets by drastically hiking marijuana-related taxes.

In all cases, elected officials are treating cannabis consumers as targets, not constituents.

These concerted attacks on state-legal marijuana markets are an explicit reminder that the war on cannabis and its consumers remains ongoing and, in some cases, is escalating. Our opponents haven’t gone away; in many cases they’ve simply regrouped and tweaked their strategies–such as by advocating for arbitrary THC potency caps or calling for new criminal penalties for consumers who don’t obtain their cannabis from state-licensed dispensaries.

Those who oppose legalization have also become bolder and more cynical in their tactics. No longer convinced that they can win the hearts and minds of voters, they are now frequently seeking to remove them from the equation altogether.

Earlier this year, Republican lawmakers in South Dakota sought to repeal the state’s voter-initiated medical cannabis access law, despite 70 percent of voters having approved it. The effort failed, but only by a single vote.

In Nebraska, lawmakers are also considering legislation to roll back that state’s voter-approved medical marijuana law and the state’s Republican attorney general has urged lawmakers to ignore the election results altogether.

In Ohio, GOP lawmakers in the Senate recently approved legislation to rescind many of the legalization provisions approved by voters in 2023. Changes advanced by lawmakers include limiting home-cultivation rights, imposing THC potency limits and creating new crimes for adults who share cannabis with one another or who purchase cannabis products from out of state.

In Texas, Republican Attorney General Ken Paxton has sued several cities, including Dallas, for implementing voter-approved ordinances decriminalizing marijuana possession. As a result, local lawmakers in various municipalities–including Lockhart and Bastrop–are ignoring voters’ decisions to rethink their marijuana policies rather than face potential litigation.

Keep reading

U.S. Embassy Warns Americans Not To Use Traditional Psychedelics In Peru, Including Ayahuasca

The U.S. embassy in Lima, Peru, is warning Americans against a traditional psychedelic known as ayahuasca, cautioning that the mixture “is a psychoactive substance containing dimethyltryptamine (DMT), a strong hallucinogen that is illegal in the United States and many other countries.”

Officials argued that using ayahuasca or kambo—a psychoactive substance derived from some frogs—can cause negative health effects and increase risks of sexual assault, robbery and other hazards.

“These dangerous substances are often marketed to travelers in Peru as ‘ceremonial’ or ‘spiritual cleansers,’” embassy officials wrote in a late January health alert to U.S. citizens, adding: “Facilities or groups offering ayahuasca/kambo are not regulated by the Peruvian government and may not follow health and safety laws or practices.”

As for ayahuasca—a mixture of botanical ingredients that contains DMT—the alert says the substance “can cause several negative health effects, including nausea, vomiting, increased heart rate, and even death.  Some of the long-term effects include psychosis, difficulty sleeping, neurological diseases, and ongoing hallucinations.”

“In 2024, several U.S. citizens died or experienced severe illness, including mental health episodes, following consumption of ayahuasca,” it continues. “These incidents often occur in remote areas near or within the Peruvian Amazon, far away from modern medical facilities. The limited connectivity and limited access to emergency services and hospitals increases the risks.”

Keep reading

Medical Marijuana Provides ‘Significant Improvements’ In Cancer Symptoms, Study Shows

A new study of medical marijuana patients in Minnesota finds that people with cancer who used cannabis “report significant improvements in cancer-related symptoms.” Nevertheless, it notes that the high cost of marijuana can be burdensome to less financially stable patients and raise “questions about affordability of and access to this therapy.”

The report, published late last month in the journal Cannabis, looked at 220 responses to a survey of patients with cancer enrolled in the Minnesota Medical Cannabis Program.

In addition to asking questions about patients’ cancer histories, cannabis use and symptom changes, the survey also included sociodemographic questions.

Results showed that while “the overwhelming majority” of patients reported symptom improvement associated with medical marijuana use, “individuals not living comfortably on their present income had higher monthly out-of-pocket costs for cannabis and were more likely to stop using cannabis or use it less than they would like; and this group more often cited cost as a reason for cannabis use disruptions.”

Keep reading

New Hampshire Lawmakers Move Forward With Plan To Legalize Simple Possession Of Marijuana

Committees in New Hampshire on Wednesday took action on a handful of marijuana bills, advancing a plan that would legalize the simple possession by adults as well as a proposal to double existing possession limits for medical cannabis patients and caregivers. They put a pause, however, on broader legislation to legalize and regulate a commercial recreational marijuana market.

At a hearing, the House Criminal Justice and Public Safety Committee gave its approval to two different bills. One—HB 198, from Rep. Jared Sullivan (D)—takes a simple, unregulated approach to marijuana legalization.

If approved, the measure would allow adults 21 and older to possess up to two ounces of marijuana flower, 10 grams of concentrate and up to 2,000 milligrams of THC in other cannabis products.

Retail sales of marijuana products, along with home cultivation, would remain illegal under the plan. Consuming marijuana on public land would also be prohibited.

Another bill—HB 190, from Rep. Heath Howard (D)—would increase the possession limit of medical marijuana by patients and caregivers, raising it to four ounces from the current two. Existing 10-day patient purchase limits would also increase from two ounces up to four.

Members of the committee voted 9–7 in favor of HB 198 and 14–0 to advance HB 190.

“We as a body have passed bills legalizing cannabis again and again,” Rep. Alissandra Murray (D), who made the motion to advance HB 198, said before Wednesday’s vote. “The people of New Hampshire have made it clear that they would like us to legalize cannabis.”

Keep reading

Using Marijuana Every Day Could Help People Quit Opioids, New Study Indicates

A newly published study found that among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men.

“Participants reporting daily cannabis use exhibited higher rates of cessation compared to less frequent users or non-users,” says the report, published last week in the journal Drug and Alcohol Review.

When results were split by sex, researchers observed that “daily cannabis use was significantly associated with increased rates of opioid cessation among males.” Those differences “suggest potential differences in cannabis use behavior and effects,” the paper says, and underscores the need for further research.

The report was authored by an eight-person research team from the British Columbia Centre on Substance Abuse as well as the University of British Columbia and Simon Fraser University.

Between June 2014 and May 2022, the team examined data from 1,242 people who used drugs (PWUD) while also living with chronic pain. Of those, 764 experienced “a cessation event.”

Daily cannabis use, it says, “was positively associated with opioid cessation.”

“Our findings add to the growing evidence supporting the potential benefits of cannabis use among PWUD, underlining the need for further research,” authors wrote.

Indeed, a growing body of research to date has examined the associations between cannabis reform and opioids, often finding reductions in opioid use in areas that legalize marijuana for medical or adult use.

A recent federally funded study in the U.S., for example, found an association between state-level marijuana legalization and reduced prescriptions for opioid pain medications among commercially insured adults—indicating a possible substitution effect where patients are choosing to use cannabis instead of prescription drugs to treat pain.

That research, which was supported by a grant from the National Institute on Drug Abuse, looked at national records of opioid prescription fills as well as prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) and other pain medications. Analysis showed that prescription opioid fills dropped following legalization in U.S. while prescribing of non-opioid pain medications saw “marginally significant increases.”

Keep reading

Arizona Lawmakers Approve Psychedelics Bills To Create Psilocybin Advisory Board And Fund Ibogaine Research

Arizona lawmakers have approved two different bills focused on psychedelic therapy.

Senate passed a bill to create an advisory board tasked with studying the science of psilocybin, as well as state and federal policies surrounding the psychedelic, while the House separately approved a measure to fund clinical trials on ibogaine.

The Senate legislation from Sen. T. J. Shope (R) cleared the chamber in a 23-4 vote on Tuesday after it was significantly amended in committee, with members removing central provisions to establish licensed psilocybin service centers for adults seeking mental health treatment.

On the House side, the body advanced the ibogaine research legislation, sponsored by Rep. Justin Wilmeth (R), in a 36-22 vote on Monday, sending it to the Senate. It would provide funding for the state Department of Health Services (DHS) to “conduct a certified clinical research study on the use of ibogaine for the treatment of neurological diseases.”

An earlier version of Shope’s Senate psilocybin bill moved through both chambers last year with the regulated access components intact, but it was vetoed by the Democratic governor, who argued that “we do not yet have the evidence needed to support widespread clinical expansion.”

However, the year before, Gov. Katie Hobbs (D) signed into law budget legislation that included provisions to fund research into the medical potential of psilocybin mushrooms for a variety of conditions.

The new Senate-passed bill hopes to leverage some of those appropriated $5 million to create an Arizona Psilocybin Advisory Board, comprised of up to 12 members appointed by the governor and legislative leaders.

Representatives of the attorney general’s office and DHS, as well as military veterans, first responders, scientists with experience with psilocybin and physicians would be among the members.

Under the bill, the board would need to be selected by December 31, 2025, and they’d need to hold their first meeting by March 1, 2026.

Keep reading

Federal Ban On Interstate Marijuana Commerce Helps The Illicit Market While Hurting Legal Businesses, California Report Finds

California officials have unveiled a new report on the current status and future of the state’s marijuana market—with independent analysts hired by regulators concluding that the federal prohibition on cannabis that prevents interstate commerce is meaningfully bolstering the illicit market.

The California Cannabis Market Outlook 2024 report—commissioned by the state Department of Cannabis Control (DCC) and carried out by ERA Economics—looked at consumer trends, industry data, regulatory enforcement actions and more.

Marketing conditions for licensed businesses “have been challenging since 2021,” the report says, noting declining wholesale cannabis prices and stagnation in transitioning adults to the regulated market. Just about 40 percent of consumers are buying from legal operators years into the implementation of legalization.

“Competition from the illicit market contributes to lower prices in the licensed market,” it says. “Some consumers still purchase cannabis from illicit operations and illicit cannabis production moves across state lines into different markets.”

“[C]annabis consumption has modestly increased and many of those consumers are purchasing cannabis from licensed cannabis businesses, but there is still a substantial illicit market in California,” it says. “Careful analysis of the data does not show an explosion of illicit market production.”

A key part of the problem is ongoing federal prohibition, according to the analysis.

“Federal legalization of cannabis and facilitation of trade between different states with licensed markets would reduce trade of illicit cannabis and could lead to more stable prices in California and other states,” it says.

The report says “wholesale prices showed that prices in the licensed markets in California, Colorado, Oregon, and Washington are related,” and this “link between the licensed cannabis markets in California, Colorado, Oregon, and Washington has increased over time.”

“The link is the unlicensed market,” it says.

“Prices in these states have converged, and statistical analysis confirms these markets are co-integrated. Market co-integration generally occurs as a result of trade between nations (or in this case, states). However, without any legal interstate trade, this result indicates that the illicit market is a driving factor that connects prices across states.”

That’s not to say that the lack of interstate commerce is the sole factor stymieing the industry, of course. The report also identifies the unregulated market for intoxicating hemp products—as well as local bans on marijuana businesses—as contributing factors.

Keep reading